RAPHAEL LEBOVITS: Open Payments
NPI 1316313182 · NEW CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 7 payments from 3 companies in 2025. Trend: 2023 $24 · 2024 $288 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $225 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| LNHC, Inc | 1 | $47 |
Products named: CEREZYME, VPRIV, ZELSUVMI.
Industry payments across NY — which companies pay providers there.
